hapabapa/iStock Editorial through Getty Pictures Bristol Myers Squibb (NYSE:BMY) introduced Saturday that its experimental schizophrenia remedy KarXT, acquired as a…
gorodenkoff TCR2 Therapeutics (NASDAQ:TCRR) stated its cell remedy gavo-cel confirmed medical profit in sufferers with mesothelin-expressing strong tumors in a…